| Literature DB >> 35999359 |
Jia-Bin Wang1,2,3, You-Xin Gao1,2,3, Yin-Hua Ye1,2,3, Tong-Xing Lin1,2,3, Ping Li1,2,3, Jian-Xian Lin1,2,3, Qi-Yue Chen1,2,3, Long-Long Cao1,2,3, Mi Lin1,2,3, Ru-Hong Tu1,2,3, Ju-Li Lin1,2,3, Ze-Ning Huang1,2,3, Hua-Long Zheng1,2,3, Jian-Wei Xie1,2,3, Chao-Hui Zheng4,5,6, Chang-Ming Huang7,8,9.
Abstract
We have demonstrated that CDK5RAP3 exerts a tumour suppressor effect in gastric cancer, but its role in regulating tumour-associated macrophages (TAMs) has not yet been reported. Here, we show that CDK5RAP3 is related to the infiltration and polarization of macrophages. It inhibits the polarization of TAMs to M2 macrophages and promotes the polarization of the M1 phenotype. CDK5RAP3 reduces the recruitment of circulating monocytes to infiltrate tumour tissue by inhibiting the CCL2/CCR2 axis in gastric cancer. Blocking CCR2 reduces the growth of xenograft tumours and the infiltration of monocytes. CDK5RAP3 inhibits the nuclear transcription of NF-κB, thereby reducing the secretion of the cytokines IL4 and IL10 and blocking the polarization of M2 macrophages. In addition, the absence of CDK5RAP3 in gastric cancer cells allows macrophages to secrete more MMP2 to promote the epithelial-mesenchymal transition (EMT) process of gastric cancer cells, thereby enhancing the invasion and migration ability. Our results imply that CDK5RAP3 may be involved in the regulation of immune activity in the tumour microenvironment and is expected to become a potential immunotherapy target for gastric cancer.Entities:
Year: 2022 PMID: 35999359 DOI: 10.1038/s41417-022-00515-9
Source DB: PubMed Journal: Cancer Gene Ther ISSN: 0929-1903 Impact factor: 5.854